Kuickresearch::Industry News

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

New Immunotherapy for Mesothelioma Enters in Clinical Trail

Release Date: 23 September 2019

A new immunotherapy is in Clinical trial phase, which is conducted by The National Cancer Institute. Their study involves 45 participants of mesothelioma.  The entire patient received a dose of LMB-100 along with tofacitinib. The&nb...

Read More


CRISPR An Advancement in Gene Therapy

Release Date: 20 September 2019

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene-editing technique that enables the targeting and editing of specific sequences in the human DNA. It is available from a period about 2 years, and recently, researchers in the U.S. have start...

Read More


Cancer Treatment with New Antibody Drug

Release Date: 20 September 2019

A new immunotherapy for the treatment of cancer has been discovered by the scientists of A star, which is an institute of molecular and Cell Biology (IMCB). They generated an antibody drug named PRL3-zumab, which is a humanised antibody ...

Read More


Modified Macrophages Can Destroy Cancer Cells

Release Date: 20 September 2019

Some of the cancers such as lung and pancreatic cancer are known as epithelial cancers. This type of cancer uses the andalpha;andnu;andbeta;3 molecule to gain drug resistance to standard cancer therapies and to become highly metastatic. ...

Read More


Initiation of Body’s Regenerative Potential by Engineered Antibodies

Release Date: 20 September 2019

The antibodies perform a major function in the prevention of the infections in body. Some of the researchers work on the potential of some synthetic versions of these molecules that is able to stimulate the regenerative ability of the bo...

Read More


Blend of PARP Inhibitors Shows Promising Activity against Small Cell Lung Cancer

Release Date: 20 September 2019

A combination of olaparib and temozolomide appeared safe and active in patient with relapsed small cell lung cancer (SLSC). Both the drugs belong to the class of Poly (ADP-ribose) polymerase (PARP) inhibitor. This result comes from the s...

Read More


Gemcitabine and Cisplatin With Enzalutamide Effectively Targets AR+ Metastatic Bladder Cancer

Release Date: 20 September 2019

The clinical data for the combination of enzalutamide (Xtandi) with gemcitabine and cisplatin shows that the effect is safe and tolerable in the case of metastatic bladder cancer. It enhances the Targeting action of androgen-receptor (AR...

Read More


Cutaneous T-Cell Lymphoma Appears Treatable Using Antibiotics

Release Date: 19 September 2019

A staphylococcal infection in the skin is commonly developed along with a rare lymphoma, known as cutaneous T-cell lymphoma (CTCL). It is a type of cancer, which affects the T-cells in the skin. CTCL can also involve the blood, lymph nod...

Read More


Clinical Trail - Effectiveness of antibiotic in Breast Cancer

Release Date: 19 September 2019

To prevent the reoccurrence of the cancer, antibiotics are studied by the researchers. Recently, clinical trail of Doxycycline was performed by the researchers in prevention of reoccurrence of cancer after surgery. An oral dose of antibi...

Read More


Nubeqa – A New Approved Treatment for Prostate Cancer

Release Date: 19 September 2019

The US FDA approved Nubeqa (darolutamide), on 30 July 2019 and it is a product of Bayer. It was an androgen receptor inhibitor, which is able to treat non-metastatic castration-resistant prostate cancer (nmCRPC). The FDA approval is base...

Read More


Stemirac – A Japanese Stem Cell Therapy for Spinal Cord Injuries

Release Date: 19 September 2019

The health ministry of japan approved Stemeric in December 2018, which is now available for Japanese population. The cost of this therapy is about US$ 140,000. This cost is able too covered under the Japan’s universal National Heal...

Read More


Dual Stem Cell Therapy shows promising action in Cardiac Regeneration

Release Date: 19 September 2019

The prevalence rate of cardiovascular disease is increasing day by day. One of them is myocardial infarction (MI), which can inflict permanent and life-threatening damage to the heart. A joint research team consisting of scientists from ...

Read More


Immune Activating Gene Therapy for Glioblastoma Enters in Clinical Trial

Release Date: 19 September 2019

A new tumor-localized gene therapy has been tested for the first time in glioblastoma patients. The testing involves a two-part approach, which consists of receiving an injection of an immune-activator gene into the brain tumor site and ...

Read More


Rapid Vaccine Delivery Can Be Achieved by Skin Patches

Release Date: 18 September 2019

The prevalence of Melanoma is increasing continuously in the US from Past 30 years. About 100,000 new cases of melanoma are diagnosed every year in US and about 20 peoples died in US every day due to melanoma. According to the American A...

Read More


92% HPV Cancer Can Be Prevented by Vaccines

Release Date: 18 September 2019

According to the study of Morbidity and Mortality Weekly Report (MMWR), an average of 43,999 cancers related with Human Papillomavirus (HPV) was reported each year during 2012 to 2016. Among the estimated 34,800 cancers probably caused b...

Read More


1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 |

Need custom market research solution? We can help you with that too.